Assuming Lymposeek is superior to the standard of care in terms of accuracy as well as patient comfort (less pain), and assume that Lymposeek therefore eventually obtains the lion's share of the existing market - what is the revenue potential for lymposeek? And - how long do people see it taking before Lymposeek realizes its potential? Thanks in advance for all knowledgeable and serious responses/comments.
How do people feel this will affect REGN stock price next week? What about the impact of how AMGN prices its drug once approved by FDA? How much do people feel AMGN has to undercut REGN's price in order to be anti-cholesterol drug? Thanks in advance for your thoughts